2-3-dihydro-1-4-dioxin-5-carboxylic-acid-[2-[4-[4-(2-methylbutan-2-yl)phenoxy]anilino]-2-oxoethyl]-ester has been researched along with Malaria* in 1 studies
1 other study(ies) available for 2-3-dihydro-1-4-dioxin-5-carboxylic-acid-[2-[4-[4-(2-methylbutan-2-yl)phenoxy]anilino]-2-oxoethyl]-ester and Malaria
Article | Year |
---|---|
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
To discover leads for next-generation chemoprotective antimalarial drugs, we tested more than 500,000 compounds for their ability to inhibit liver-stage development of luciferase-expressing Topics: Antimalarials; Chemoprevention; Drug Discovery; Drug Evaluation, Preclinical; Humans; Malaria; Mitochondria; Plasmodium | 2018 |